Tian Denghan, a distinguished expert, deputy chief physician, associate professor and andrology expert of Wu Jieping Urology Medical Center in Peking University. He is the founder of clinical research on the treatment of benign prostatic hyperplasia without surgery and bleeding in China.

Chinese name: Tian Denghan

Nationality: China.

Occupation: doctor

Masterpiece: analysis of therapeutic effect of high energy ablation on 30 cases of benign prostatic hyperplasia

brief introduction

Invited expert of Changchun Peking University Prostate Disease Hospital, invited expert of Wuhan Apollo Hospital, deputy chief physician and associate professor. Chief consultant of andrology expert, graduated from Suzhou Medical College in his early years, and is the chief physician of the Air Force.

Specially invited expert, deputy chief physician, associate professor, expert consulting column expert of Beijing Municipal Health Bureau, and "World Science and Technology Consulting Expert" in Hong Kong. Former deputy chief physician of urology department of Peking Union Medical College Hospital. Good at: urinary infectious diseases, prostatitis, prostatic hyperplasia.

He has been a doctor for more than 30 years, and served as the head of urology professional group from 65438 to 0985. 1996 independent chief surgeon completed 7 indexes of urology specified by a third-class first-class hospital, and the first batch entered the top three ranks. There were no deaths and serious complications in all operations.

From 65438 to 0985 to 2004, he served as the medical and health care work for cadres at the ministerial level.

1984 participated in the research and development of prostate field effect ablation technology. 1985, field effect ablation was formally applied to clinical work, and nearly 2000 patients with prostatitis and prostatic hyperplasia have been treated. The curative effect is much higher than that of radio frequency, microwave, laser, surgery, iontophoresis, electrochemistry, interventional fusion and local injection. He is the founder of domestic clinical research on the treatment of benign prostatic hyperplasia without surgery, surgery and bleeding.

Professor Tian Denghan, deputy chief physician of urology department of Peking Union Medical College Hospital, gave a special report on "Clinical research and application of field effect ablation"

Major achievements

Published more than 10 papers in my work, including representative papers:

Analysis of therapeutic effect of high-energy ablation on 30 cases of benign prostatic hyperplasia, Chinese Journal of Gerontology.

Experience of transurethral resection of prostate (150 cases): a compendium of world excellent medical papers

TUR Treatment of Ectopic Posterior Ureteral Opening: National Conference on Innovative Surgery

Hydroelectric effect bladder lithotomy Beijing science and technology news

Evaluation of the efficacy of field effect ablation in the treatment of gonococcal prostatitis by China Gerontology Society.

Awards: 1 Item: 1997 won the national patent "utility model".

Works: 2 items: among them, representative works: > (China Volume-),

& gt 1998 was awarded the title of "World Medical Consulting Expert" by Hong Kong.

2001February was hired as an expert consultant by Beijing Municipal Health Bureau.

In addition, papers such as "properly stop bleeding and improve TURP quality" were exchanged and published at academic conferences. Social position: Medical consultant of China Gerontology Society.

achievements in scientific research

He has been a doctor for more than 30 years, and served as the head of urology professional group from 65438 to 0985. 1996 independent chief surgeon completed 7 indexes of urology specified by a third-class first-class hospital, and the first batch entered the top three ranks. There were no deaths and serious complications in all operations.

1984 participated in the research and development of prostate field effect ablation technology. 1995, field effect ablation was formally applied to clinical work, and nearly 2000 patients with prostatitis and prostatic hyperplasia have been treated. The curative effect is much higher than that of radio frequency, microwave, laser, surgery, iontophoresis, electrochemistry, interventional fusion and local injection. Professor Tian Denghan is the founder of clinical research on benign prostatic hyperplasia without surgery, surgery and bleeding treatment in China. 2008 China Minimally Invasive Urology Summit Forum and "Prostate Field Effect Ablation" Seminar was held in Diaoyutai State Guesthouse on June 5438+1October 65438+August. Professor Tian Denghan, an expert in urology at Peking Union Medical College Hospital, was invited to attend and gave a special report on "Clinical Research and Application of Field Effect Ablation".

In September 2009, the prostate field effect ablation was upgraded to Zhiyuan peptide prostate treatment system, which realized real-time temperature control and temperature measurement, and the curative effect was better. Beijing Oriental Boda Hospital has become the national clinical treatment training base for Zhiyuan peptide prostate treatment, and Professor Tian Denghan is personally responsible for the clinical treatment training and promotion of this technology.

Honor achievement

Awards: 1 Item: 1997 was awarded the title of "world medical consultation expert" by the national patent "utility model" 1998, and was hired as an "expert consultation" expert by the Beijing Municipal Health Bureau in February.

Be good at fields

Urology, prostatitis, prostatic hyperplasia, penile lengthening.